Zendia GmbH proudly launched its first field feasibility study, a collaboration with the medical faculty at Ugandan Christian University. Under the expert guidance of Dr. Gerald Tumussime and his dedicated team in Kampala, this study marks a significant milestone for InfectoTest® as it transitions from a development laboratory into the real world setting, with actual blood samples from malaria patients. This is a big leap forward for our field application, and we look forward to the invaluable insights this study will bring. We are extremely excited to see our assay put to the test in real world conditions!
Zendia Embarks on First InfectoTest® Feasibility Study in Kampala, Uganda
Previous articleEthical Committee Endorses Zendia's Study Protocol for Rapid Malaria DiagnosticsNext article Joint Venture with Charité Universitätsmedizin & Berlin Johann Wolfgang Goethe University
1 comment
Comments are closed.
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.